C200-1103 Screening compound: N~1~-(4-ETHYLPHENYL)-2-({2-OXO-3-[3-OXO-3-(PHENETHYLAMINO)PROPYL]-2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLIN-5-YL}SULFANYL)BUTANAMIDE

C200-1103 Screening compound: N~1~-(4-ETHYLPHENYL)-2-({2-OXO-3-[3-OXO-3-(PHENETHYLAMINO)PROPYL]-2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLIN-5-YL}SULFANYL)BUTANAMIDE
C200-1103 Screening compound: N~1~-(4-ETHYLPHENYL)-2-({2-OXO-3-[3-OXO-3-(PHENETHYLAMINO)PROPYL]-2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLIN-5-YL}SULFANYL)BUTANAMIDE alternative view

Chemical Structure Depiction of ChemDiv screening compound C200-1103
N~1~-(4-ETHYLPHENYL)-2-({2-OXO-3-[3-OXO-3-(PHENETHYLAMINO)PROPYL]-2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLIN-5-YL}SULFANYL)BUTANAMIDE

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C200-1103

Molecular Formula

C33H35N5O3S (C33 H35 N5 O3 S)

Compound Name

N~1~-(4-ETHYLPHENYL)-2-({2-OXO-3-[3-OXO-3-(PHENETHYLAMINO)PROPYL]-2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLIN-5-YL}SULFANYL)BUTANAMIDE

IUPAC name

n/a

SMILES

CCC(C(Nc1ccc(CC)cc1)=O)SC(N1C2CCC(NCCc3ccccc3)=O)=Nc(cccc3)c3C1=NC2=O

InChI

InChI=1S/C33H35N5O3S/c1-3-22-14-16-24(17-15-22)35-32(41)28(4-2)42-33-36-26-13-9-8-12-25(26)30-37-31(40)27(38(30)33)18-19-29(39)34-21-20-23-10-6-5-7-11-23/h5-17,27-28H,3-4,18-21H2,1-2H3,(H,34,39)(H,35,41)

InChI Key

JKILSYKNABJMIA-UHFFFAOYSA-N

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

581.74

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

14.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

4.758

Distribution Coefficient, logD

4.757

Water Solubility, LogSw

-4.51

Polar Surface Area

82.827

Acid Dissociation Constant (pKa)

10.29

Base Dissociation Constant (pKb)

4.20

Number of Chiral Centers

2.00

Percent sp3 carbon bonding

30.30

C200-1103 in Drug Discovery

Included in Screening Libraries

Histone Deacetylases (HDAC) Targeted Library (9760 compounds)

MCE-18 Trends in Medicinal Chemistry (51288 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Nervous system
  • Hemic and lymphatic
  • Endocrine
  • Immune system
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Mechanism of action:
  • Epigenetic
Targets:
  • Phosphatases

References: we are preparing a list of scientific research reports with C200-1103 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C200-1103?
Check Price and Availability of C200-1103, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C200-1103 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C200-1103
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C200-1103
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C200-1103 available by request